O
Opko Health Inc (OPK)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
$1.62
-0.06 (-3.57%)
Market Cap: $1.25B
Last updated: Nov 17, 2026 at 11:06 AM ET
Opko Health Inc (OPK) Valuation Multiples
Opko Health (OPK) trades at 2.4x sales and 1.1x book value. Its P/S of 2.4x is above its 5-year median of 1.4x. Its forward P/E is 53.8x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 53.8x |
| Price to sales | 2.4x |
| Price to book | 1.1x |
| PEG | N/A |
| FCF yield | -11.2% |
Historical Medians
Against its 10-year medians, its P/S is 60.0% above 1.5x and its P/B is 22.2% above 0.9x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 2.4x | 1.4x | 1.5x |
| P/B | 1.1x | 0.8x | 0.9x |
Valuation History
Over the 10 year ends shown, its P/S ranged from 0.9x in 2022 to 4.6x in 2016.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $1.26 | N/A | 1.8x | 0.8x |
| 2024 | $1.47 | N/A | 1.4x | 0.7x |
| 2023 | $1.51 | N/A | 1.3x | 0.8x |
| 2022 | $1.25 | N/A | 0.9x | 0.6x |
| 2021 | $4.81 | N/A | 1.8x | 1.9x |
| 2020 | $3.95 | 79.0x | 1.8x | 1.5x |
| 2019 | $1.47 | N/A | 1.0x | 0.6x |
| 2018 | $3.01 | N/A | 1.7x | 1.0x |
| 2017 | $4.90 | N/A | 1.6x | 1.5x |
| 2016 | $9.30 | N/A | 4.6x | 2.5x |
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About OPK
What is OPK's forward P/E ratio?
Opko Health has a forward P/E ratio of 53.8x.
Is OPK stock overvalued?
GNG's valuation label for OPK is Overvalued.
What is OPK's price to sales ratio?
Opko Health has a price to sales ratio of 2.4x.
OPK pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts